New Insights in the Era of Clinical Biomarkers as Potential Predictors of Systemic Therapy-Induced Cardiotoxicity in Women with Breast Cancer: A Systematic Review.

Autor: Alexandraki A; A.G. Leventis Clinical Trials Unit, Bank of Cyprus Oncology Centre, 32 Acropoleos Avenue, Nicosia 2006, Cyprus., Papageorgiou E; A.G. Leventis Clinical Trials Unit, Bank of Cyprus Oncology Centre, 32 Acropoleos Avenue, Nicosia 2006, Cyprus., Zacharia M; A.G. Leventis Clinical Trials Unit, Bank of Cyprus Oncology Centre, 32 Acropoleos Avenue, Nicosia 2006, Cyprus., Keramida K; 2nd Department of Cardiology, Attikon University Hospital, National and Kapodistrian University of Athens, 12462 Athens, Greece.; Cardiology Department, General Anti-Cancer Oncological Hospital, Agios Savvas, 11522 Athens, Greece., Papakonstantinou A; Department of Oncology-Pathology, Karolinska Institute, 17176 Stockholm, Sweden.; Department for Breast, Endocrine Tumours and Sarcoma, Karolinska University Hospital, 17176 Stockholm, Sweden., Cipolla CM; Cardioncology and Second Opinion Division, European Institute of Oncology (IEO), IRCCS, Via Ripamonti 435, 20141 Milan, Italy., Tsekoura D; 2nd Department of Surgery, Aretaieio University Hospital, National and Kapodistrian University of Athens, 76 Vas. Sofias Av., 11528 Athens, Greece., Naka K; 2nd Cardiology Department, University of Ioannina Medical School, 45110 Ioannina, Greece., Mazzocco K; Applied Research Division for Cognitive and Psychological Science, European Institute of Oncology IRCCS, 20139 Milan, Italy.; Department of Oncology and Hemato-Oncology, University of Milan, 20122 Milan, Italy., Mauri D; Department of Medical Oncology, University of Ioannina, 45110 Ioannina, Greece., Tsiknakis M; Department of Electrical and Computer Engineering, Hellenic Mediterranean University, 71410 Heraklion, Greece.; Computational BioMedicine Laboratory (CBML), Institute of Computer Science, Foundation for Research and Technology Hellas (FORTH), 70013 Heraklion, Greece., Manikis GC; Computational BioMedicine Laboratory (CBML), Institute of Computer Science, Foundation for Research and Technology Hellas (FORTH), 70013 Heraklion, Greece., Marias K; Department of Electrical and Computer Engineering, Hellenic Mediterranean University, 71410 Heraklion, Greece.; Computational BioMedicine Laboratory (CBML), Institute of Computer Science, Foundation for Research and Technology Hellas (FORTH), 70013 Heraklion, Greece., Marcou Y; Department of Medical Oncology, Bank of Cyprus Oncology Centre, 32 Acropoleos Avenue, Nicosia 2006, Cyprus., Kakouri E; Department of Medical Oncology, Bank of Cyprus Oncology Centre, 32 Acropoleos Avenue, Nicosia 2006, Cyprus., Konstantinou I; Department of Medical Oncology, Bank of Cyprus Oncology Centre, 32 Acropoleos Avenue, Nicosia 2006, Cyprus., Daniel M; Department of Radiation Oncology, Bank of Cyprus Oncology Centre, 32 Acropoleos Avenue, Nicosia 2006, Cyprus., Galazi M; Department of Medical Oncology, Bank of Cyprus Oncology Centre, 32 Acropoleos Avenue, Nicosia 2006, Cyprus., Kampouroglou E; 2nd Department of Surgery, Aretaieio University Hospital, National and Kapodistrian University of Athens, 76 Vas. Sofias Av., 11528 Athens, Greece., Ribnikar D; Division of Medical Oncology, Institute of Oncology Ljubljana, Faculty of Medicine, University of Ljubljana, Zaloska Cesta 2, 1000 Ljubljana, Slovenia., Brown C; Translational Medicine, Stremble Ventures Ltd., 59 Christaki Kranou, Limassol 4042, Cyprus., Karanasiou G; Biomedical Research Institute, Foundation for Research and Technology, Hellas, 45500 Ioannina, Greece., Antoniades A; Research and Development, Stremble Ventures Ltd., 59 Christaki Kranou, Limassol 4042, Cyprus., Fotiadis D; Unit of Medical Technology and Intelligent Information Systems, Department of Materials Science and Engineering, University of Ioannina, 45110 Ioannina, Greece., Filippatos G; Cardio-Oncology Clinic, Heart Failure Unit, Department of Cardiology, National and Kapodistrian University of Athens Medical School, Athens University Hospital Attikon, 11527 Athens, Greece., Constantinidou A; Department of Medical Oncology, Bank of Cyprus Oncology Centre, 32 Acropoleos Avenue, Nicosia 2006, Cyprus.; School of Medicine, University of Cyprus, Panepistimiou 1, Aglantzia, Nicosia 2408, Cyprus.

Publikováno v: Cancers [Cancers (Basel)] 2023 Jun 22; Vol. 15 (13). Date of Electronic Publication: 2023 Jun 22.

Clinical portrait of the SARS-Cov-2 epidemic in European cancer patients

Autor: Pinato DJ, Zambelli A, Aguilar-Company J, Bower M, Sng C, Salazar R, Bertuzzi A, Brunet J, Mesia R, Segui E, Biello F, Generali D, Grisanti S, Rizzo G, Libertini M, Maconi A, Harbeck N, Vincenzi B, Bertulli R, Ottaviani D, Carbo A, Bruna R, Benafif S, Marrari A, Wuerstlein R, Carmona-Garcia MC, Chopra N, Tondini C, Mirallas O, Tovazzi V, Betti M, Provenzano S, Fotia V, Cruz CA, Dalla Pria A, D'Avanzo F, Evans JS, Saoudi-Gonzalez N, Felip E, Galazi M, Garcia-Fructuoso I, Lee AJX, Newsom-Davis T, Patriarca A, Garcia-Illescas D, Reyes R, Dileo P, Sharkey R, Wong YNS, Ferrante D, Marco-Hernandez J, Sureda A, Maluquer C, Ruiz-Camps I, Gaidano G, Rimassa L, Chiudinelli L, Izuzquiza M, Cabirta A, Franchi M, Santoro A, Prat A, Tabernero J, Gennari A

Publikováno v: Cancer Discovery
r-IGTP. Repositorio Institucional de Producción Científica del Instituto de Investigación Germans Trias i Pujol
instname

The SARS-Cov-2 pandemic significantly impacted on oncology practice across the globe. There is uncertainty as to the contribution of patients' demographics and oncological features on severity and mortality from Covid-19 and little guidance as to the

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=dedup_wf_001::040e4a589c765a892bbec1b99c266a70
http://hdl.handle.net/10044/1/81253

Predicting progression-free survival after systemic therapy in advanced head and neck cancer: Bayesian regression and model development.

Autor: Barber PR; UCL Cancer Institute, Paul O'Gorman Building, University College London, London, United Kingdom.; Comprehensive Cancer Centre, School of Cancer & Pharmaceutical Sciences, King's College London, London, United Kingdom., Mustapha R; Richard Dimbleby Laboratory of Cancer Research, School of Cancer & Pharmaceutical Sciences, King's College London, London, United Kingdom., Flores-Borja F; Breast Cancer Now Research Unit, School of Cancer & Pharmaceutical Sciences, King's College London, London, United Kingdom., Alfano G; Richard Dimbleby Laboratory of Cancer Research, School of Cancer & Pharmaceutical Sciences, King's College London, London, United Kingdom., Ng K; UCL Cancer Institute, Paul O'Gorman Building, University College London, London, United Kingdom., Weitsman G; Richard Dimbleby Laboratory of Cancer Research, School of Cancer & Pharmaceutical Sciences, King's College London, London, United Kingdom., Dolcetti L; Richard Dimbleby Laboratory of Cancer Research, School of Cancer & Pharmaceutical Sciences, King's College London, London, United Kingdom., Suwaidan AA; Richard Dimbleby Laboratory of Cancer Research, School of Cancer & Pharmaceutical Sciences, King's College London, London, United Kingdom., Wong F; Richard Dimbleby Laboratory of Cancer Research, School of Cancer & Pharmaceutical Sciences, King's College London, London, United Kingdom., Vicencio JM; UCL Cancer Institute, Paul O'Gorman Building, University College London, London, United Kingdom.; Richard Dimbleby Laboratory of Cancer Research, School of Cancer & Pharmaceutical Sciences, King's College London, London, United Kingdom., Galazi M; UCL Cancer Institute, Paul O'Gorman Building, University College London, London, United Kingdom., Opzoomer JW; Tumor Immunology Group, School of Cancer & Pharmaceutical Sciences, King's College London, London, United Kingdom., Arnold JN; Tumor Immunology Group, School of Cancer & Pharmaceutical Sciences, King's College London, London, United Kingdom., Thavaraj S; Centre for Clinical, Oral & Translational Science, King's College London, London, United Kingdom., Kordasti S; Systems Cancer Immunology, School of Cancer & Pharmaceutical Sciences, King's College London, London, United Kingdom., Doyle J; Daiichi Sankyo Incorporated, Newark, United States., Greenberg J; Daiichi Sankyo Incorporated, Newark, United States., Dillon MT; The Institute of Cancer Research, London, United Kingdom., Harrington KJ; The Institute of Cancer Research, London, United Kingdom., Forster M; UCL Cancer Institute, Paul O'Gorman Building, University College London, London, United Kingdom., Coolen ACC; Institute for Mathematical and Molecular Biomedicine, King's College London, London, United Kingdom.; Saddle Point Science Ltd, London, United Kingdom., Ng T; UCL Cancer Institute, Paul O'Gorman Building, University College London, London, United Kingdom.; Richard Dimbleby Laboratory of Cancer Research, School of Cancer & Pharmaceutical Sciences, King's College London, London, United Kingdom.; Breast Cancer Now Research Unit, School of Cancer & Pharmaceutical Sciences, King's College London, London, United Kingdom.

Publikováno v: ELife [Elife] 2022 Dec 23; Vol. 11. Date of Electronic Publication: 2022 Dec 23.

1575P Systemic anti-cancer therapy and metastatic cancer are independent mortality risk factors during two UK waves of the COVID-19 pandemic at University College London Hospital

Autor: Sinclair, A., Earnshaw, I., Chowdhury, A., Patel, G., Chopra, N., Merry, E., Soosaipillai, G., Galazi, M., Benafif, S., Wu, A., Sng, C., Wong, Y.N.S., Ottaviani, D., Shaw, H., Lee, A.J.X., Roylance, R.

Publikováno v: In Annals of Oncology September 2021 32 Supplement 5:S1138-S1138

COVID-19 in breast cancer patients: a subanalysis of the OnCovid registry.

Autor: Garrigós L; Department of Medical Oncology, Vall d'Hebron University Hospital and Vall d'Hebron Institute of Oncology (VHIO), Barcelona, Spain., Saura C; Head Breast Cancer Unit, Vall d'Hebron University Hospital and Principal Investigator Breast Group, Vall d'Hebron Institute of Oncology (VHIO), Passeig Vall d'Hebrón 119-129, 08035 Barcelona, Spain., Martinez-Vila C; Department of Oncology, Hospital Althaia Manresa, Barcelona, Spain., Zambelli A; Oncology Unit, ASST Papa Giovanni XXIII, Bergamo, Italy., Bower M; Department of Oncology and National Centre for HIV Malignancy, Chelsea and Westminster Hospital, London, UK., Pistilli B; Department of Medical Oncology, Institute Gustave-Roussy, Villejuif, France., Lambertini M; Department of Medical Oncology, UOC Clinica di Oncologia Medica, IRCCS Policlinico San Martino Hospital, Genoa, Italy., Ottaviani D; Cancer Division, University College London Hospitals, London, UK., Diamantis N; Medical Oncology, Barts Health NHS Trust, London, UK., Lumsden A; Translational Oncology & Urology Research (TOUR), School of Cancer and Pharmaceutical Sciences, King's College London, London, UK., Pernas S; Department of Medical Oncology, Catalan Institute of Oncology, L'Hospitalet, Spain., Generali D; Multidisciplinary Breast Pathology and Translational Research Unit, ASST Cremona, Casalmaggiore, Italy., Seguí E; Department of Medical Oncology, Hospital Clinic, Barcelona, Spain., Viñas G; Department of Medical Oncology, Catalan Institute of Oncology, University Hospital Josep Trueta, Girona, Spain., Felip E; Department of Medical Oncology, Catalan Institute of Oncology, Badalona, Spain., Sanchez A; Department Medical Oncology, Hospital XII de Octubre, Madrid, Spain., Rizzo G; Medical Oncology Unit, Fondazione IRCCS Policlinico San Matteo, University of Pavia, Pavia, Italy., Santoro A; IRCCS Humanitas Research Hospital, Humanitas Cancer Center, Milan, Italy., Cortellini A; Department of Biotechnology and Applied Clinical Sciences, University of L'Aquila, L'Aquila, Italy., Perone Y; Medical Oncology, Velindre Cancer Centre, Cardiff, UK., Chester J; Medical Oncology, Velindre Cancer Centre, Cardiff, UK., Iglesias M; Department of Oncology, Hospital Universitario Son Llatzer, Palma de Mallorca, Spain., Betti M; Research Infrastructure, Research and Innovation Department, Azienda Ospedaliera 'SS Antonio e Biagio e Cesare Arrigo', Alessandria, Italy., Vincenzi B; Department of Oncology, University 'Campus Bio-Medico', Rome, Italy., Libertini M; Medical Oncology Unit, Fondazione Poliambulanza Istituto Ospedaliero, Brescia, Italy., Mazzoni F; Department of Oncology, Careggi University Hospital, Florence, Italy., Zoratto F; Medical Oncology, Santa Maria Goretti Hospital, Latina, Italy., Berardi R; Oncology Clinic, Università Politecnica Delle Marche, Ospedali Riuniti Di Ancona, Ancona, Italy., Guida A; Struttura Complessa di Oncologia Medica e Traslazionale, Azienda Ospedaliera Santa Maria di Terni, Italy., Wuerstlein R; Department of Gynecology and Obstetrics, Breast Center and Gynecological Cancer Center and CCC Munich, University Hospital Munich, Munich, Germany., Loizidou A; Department of Oncology, Institut Jules Bordet, Université Libre de Bruxelles, Belgium., Sharkey R; Department of Oncology and National Centre for HIV Malignancy, Chelsea and Westminster Hospital, London, UK., Aguilar Company J; Department of Medical Oncology, Vall d'Hebron University Hospital and Vall d'Hebron Institute of Oncology (VHIO), Barcelona, Spain., Matas M; Department of Oncology, Hospital Althaia Manresa, Barcelona, Spain., Saggia C; Department of Translational Medicine, University of Piemonte Orientale, Azienda Ospedaliero-Universitaria Maggiore della Carità, Novara, Italy., Chiudinelli L; Oncology Unit, ASST Papa Giovanni XXIII, Bergamo, Italy., Colomba-Blameble E; Department of Medical Oncology, Institute Gustave-Roussy, Villejuif, France., Galazi M; Cancer Division, University College London Hospitals, London, UK., Mukherjee U; Medical Oncology, Barts Health NHS Trust, London, UK., Van Hemelrijck M; Translational Oncology & Urology Research (TOUR), School of Cancer and Pharmaceutical Sciences, King's College London, London, UK., Marin M; Department of Medical Oncology, Catalan Institute of Oncology, L'Hospitalet (Barcelona), Spain., Strina C; Multidisciplinary Breast Pathology and Translational Research Unit, ASST Cremona, Casalmaggiore, Italy., Prat A; Department of Medical Oncology, Hospital Clinic, Barcelona, Spain., Pla H; Department of Medical Oncology, Catalan Institute of Oncology, University Hospital Josep Trueta, Girona, Spain., Ciruelos EM; Department Medical Oncology, Hospital XII de Octubre, Madrid, Spain., Bertuzzi A; IRCCS Humanitas Research Hospital, Humanitas Cancer Center, Milan, Italy., Del Mastro L; Breast Unit, IRCCS Policlinico San Martino Hospital, Genoa, Italy., Porzio G; Medical Oncology Unit, San Salvatore Hospital, L'Aquila, Italy., Newsom-Davis T; Department of Oncology and National Centre for HIV Malignancy, Chelsea and Westminster Hospital, London, UK., Ruiz I; Department of Infectious Diseases, Vall d'Hebron University Hospital, Barcelona, Spain., Delany MB; Department of Oncology, Hospital Althaia Manresa, Barcelona, Spain., Krengli M; Division of Radiotherapy, Department of Translational Medicine, University of Eastern Piedmont and Hospital 'Maggiore della Carità', Novara, Italy., Fotia V; Oncology Unit, ASST Papa Giovanni XXIII, Bergamo, Italy., Viansone A; Department of Medical Oncology, Institute Gustave-Roussy, Villejuif, France., Chopra N; Cancer Division, University College London Hospitals, London, UK., Romeo M; Department of Medical Oncology, Catalan Institute of Oncology, Badalona, Spain., Salazar R; Department of Medical Oncology, Catalan Institute of Oncology, L'Hospitalet (Barcelona), Spain., Perez I; Department of Oncology, Hospital Althaia Manresa, Barcelona, Spain., d'Avanzo F; Department of Translational Medicine, University of Piemonte Orientale, Azienda Ospedaliero-Universitaria Maggiore della Carità, Novara, Italy., Franchi M; Oncology Unit, ASST Papa Giovanni XXIII, Bergamo, Italy., Milani M; Multidisciplinary Breast Pathology and Translational Research Unit, ASST Cremona, Casalmaggiore, Italy., Pommeret F; Department of Medical Oncology, Institute Gustave-Roussy, Villejuif, France., Tucci M; Department of Biomedical Sciences and Human Oncology, University of Bari Aldo Moro, Bari, Italy., Pedrazzoli P; Medical Oncology Unit, Fondazione IRCCS Policlinico San Matteo, University of Pavia, Pavia, Italy., Harbeck N; Department of Gynecology and Obstetrics, Breast Center and Gynecological Cancer Center and CCC Munich, University Hospital Munich, Munich, Germany., Ferrante D; Department of Translational Medicine, Unit of Medical Statistics, University of Piemonte Orientale and Cancer Epidemiology, CPO Piemonte, Novara, Italy., Pinato DJ; Division of Surgery and Cancer, Hammersmith Hospital, Imperial College London, London, UK., Gennari A; Department of Translational Medicine, University of Piemonte Orientale, Azienda Ospedaliero-Universitaria Maggiore della Carità, Novara, Italy.

Publikováno v: Therapeutic advances in medical oncology [Ther Adv Med Oncol] 2021 Nov 02; Vol. 13, pp. 17588359211053416. Date of Electronic Publication: 2021 Nov 02 (Print Publication: 2021).